Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study

Oslo University Hospital100 enrolled

Overview

There is growing evidence that psoriasis is a systemic disorder which enhances atherosclerosis and the risk of cardiovascular disease. Epidemiological studies have shown an independent association between psoriasis and atherosclerosis, stroke and coronary artery disease. The main goal of this on-going study is to register data which will enable the identification of new markers of atherosclerosis activity and carotid plaque instability in patients with severe psoriasis.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Psoriasis Cardiovascular Disease

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * \>18 years old, psoriasis for more than 5 years, moderate to severe psoriasis (PASI \>10 or systemic treatment) Exclusion Criteria: * familiar hypercholesterolemia, ongoing infections and cancer disease

Locations (2)

Dermatological Department, OUS

Oslo, Norway

Oslo university Hospital, Dermatological dept

Oslo, Norway

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.